These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2574673)

  • 1. Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man.
    Widerlöv E; Termander B; Nilsson MI
    Eur J Clin Pharmacol; 1989; 37(4):359-63. PubMed ID: 2574673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers.
    Grind M; Nilsson MI; Nilsson L; Oxenstierna G; Sedvall G; Wahlén A
    Psychopharmacology (Berl); 1989; 98(3):304-9. PubMed ID: 2568653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of urinary pH on the disposition of methadone in man.
    Nilsson MI; Widerlöv E; Meresaar U; Anggård E
    Eur J Clin Pharmacol; 1982; 22(4):337-42. PubMed ID: 6286317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remoxipride: pharmacokinetics and effect on plasma prolactin.
    Movin-Osswald G; Hammarlund-Udenaes M
    Br J Clin Pharmacol; 1991 Sep; 32(3):355-60. PubMed ID: 1685665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of remoxipride.
    von Bahr C; Movin G; Yisak WA; Jostell KG; Widman M
    Acta Psychiatr Scand Suppl; 1990; 358():41-4. PubMed ID: 1978486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers.
    Farde L; Grind M; Nilsson MI; Ogenstad S; Sedvall G
    Psychopharmacology (Berl); 1988; 95(2):157-61. PubMed ID: 2901121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics.
    Neuvonen PJ; Kärkkäinen S
    Clin Pharmacol Ther; 1983 Mar; 33(3):386-93. PubMed ID: 6297841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia.
    Widerlöv E; Andersson U; von Bahr C; Nilsson MI
    Psychopharmacology (Berl); 1991; 103(1):46-9. PubMed ID: 1672458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interaction studies with remoxipride.
    Yisak W; von Bahr C; Farde L; Grind M; Mattila M; Ogenstad S
    Acta Psychiatr Scand Suppl; 1990; 358():58-62. PubMed ID: 1978492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers.
    von Bahr C; Wiesel FA; Movin G; Eneroth P; Jansson P; Nilsson L; Ogenstad S
    Psychopharmacology (Berl); 1991; 103(4):443-8. PubMed ID: 1676524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients.
    Widerlöv E; Franzén G; Jansson P; Movin G
    Int Clin Psychopharmacol; 1990 Apr; 5(2):125-34. PubMed ID: 1974271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparfloxacin pharmacokinetics in healthy volunteers: the influence of acidification and alkalinization.
    Kamberi M; Kotegawa T; Tsutsumi K; Nakamura K; Nakano S
    Eur J Clin Pharmacol; 1998 Oct; 54(8):633-7. PubMed ID: 9860151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of urine pH on debrisoquine phenotyping: application of an HPLC-method.
    Kallio J
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):223-6. PubMed ID: 2163994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):326-32. PubMed ID: 3015809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia.
    Tench D; Soni SD; Ashwood T; Movin G
    Psychopharmacology (Berl); 1990; 101(1):132-6. PubMed ID: 1971445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of urinary pH and urine flow rate on prostaglandin E2 and kallikrein excretion by the conscious dog.
    Filep J; Földes-Filep E
    J Physiol; 1987 Feb; 383():1-8. PubMed ID: 2821232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remoxipride in schizophrenia: effects on plasma prolactin.
    Chouinard G; Turnier L; Kallai-Sanfacon MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):599-603. PubMed ID: 2868493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.